147 related articles for article (PubMed ID: 1646754)
1. Correlation of plasma methotrexate concentration with human chorionic gonadotropin and therapeutic response to low-dose methotrexate-citrovorum factor in low-medium-risk gestational trophoblastic tumors.
Hilgers RD; Newlands ES; Hoffman R; Mitchell H; Bagshawe KD
Gynecol Oncol; 1991 May; 41(2):117-22. PubMed ID: 1646754
[TBL] [Abstract][Full Text] [Related]
2. Serum methotrexate and human chorionic gonadotropin concentrations during five-day chemotherapy for low-risk metastatic gestational trophoblastic neoplasia.
Hilgers RD; Standefer JC; Bowling MC; Greeley P
Int J Gynaecol Obstet; 1988 Dec; 27(3):421-5. PubMed ID: 2904909
[TBL] [Abstract][Full Text] [Related]
3. High-dose methotrexate for gestational trophoblastic disease.
Elit L; Covens A; Osborne R; Gerulath A; Murphy J; Rosen B; Sturgeon J
Gynecol Oncol; 1994 Sep; 54(3):282-7. PubMed ID: 7522198
[TBL] [Abstract][Full Text] [Related]
4. Methotrexate with citrovorum factor rescue for nonmetastatic gestational trophoblastic neoplasms.
Berkowitz RS; Goldstein DP
Obstet Gynecol; 1979 Dec; 54(6):725-8. PubMed ID: 229448
[TBL] [Abstract][Full Text] [Related]
5. Plasma methotrexate levels in patients with gestational trophoblastic neoplasia treated by two methotrexate regimens.
Rotmensch J; Rosenshein N; Donehower R; Dillon M; Villar J
Am J Obstet Gynecol; 1984 Mar; 148(6):730-4. PubMed ID: 6199978
[TBL] [Abstract][Full Text] [Related]
6. Development of single-agent chemotherapy regimens for gestational trophoblastic disease.
Homesley HD
J Reprod Med; 1994 Mar; 39(3):185-92. PubMed ID: 7518517
[TBL] [Abstract][Full Text] [Related]
7. Low-risk persistent gestational trophoblastic disease: outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000.
McNeish IA; Strickland S; Holden L; Rustin GJ; Foskett M; Seckl MJ; Newlands ES
J Clin Oncol; 2002 Apr; 20(7):1838-44. PubMed ID: 11919242
[TBL] [Abstract][Full Text] [Related]
8. Trophoblastic cell sensitivity to 8-day chemotherapy in nonmetastatic gestational trophoblastic neoplasia.
Hilgers RD; Standefer JC; Rutledge JM; Ampuero F
Gynecol Oncol; 1984 Mar; 17(3):386-93. PubMed ID: 6200387
[TBL] [Abstract][Full Text] [Related]
9. Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors.
Newlands ES; Mulholland PJ; Holden L; Seckl MJ; Rustin GJ
J Clin Oncol; 2000 Feb; 18(4):854-9. PubMed ID: 10673528
[TBL] [Abstract][Full Text] [Related]
10. Methotrexate with citrovorum factor rescue for gestational trophoblastic neoplasms.
Goldstein DP; Saracco P; Osathanondh R; Goldstein PR; Marean AR; Bernstein MR
Obstet Gynecol; 1978 Jan; 51(1):93-6. PubMed ID: 201893
[TBL] [Abstract][Full Text] [Related]
11. Comparison of chemotherapies with methotrexate, VP-16 and actinomycin-D in low-risk gestational trophoblastic disease. Remission rates and drug toxicities.
Matsui H; Iitsuka Y; Seki K; Sekiya S
Gynecol Obstet Invest; 1998; 46(1):5-8. PubMed ID: 9692333
[TBL] [Abstract][Full Text] [Related]
12. Weekly intramuscular methotrexate for nonmetastatic gestational trophoblastic disease.
Homesley HD; Blessing JA; Rettenmaier M; Capizzi RL; Major FJ; Twiggs LB
Obstet Gynecol; 1988 Sep; 72(3 Pt 1):413-8. PubMed ID: 2457192
[TBL] [Abstract][Full Text] [Related]
13. Failure of single dose methotrexate followed by citrovorum factor in nonmetastatic gestational trophoblastic neoplasia.
Hilgers RD; Hermann JJ; Standefer JC
Gynecol Oncol; 1990 Jun; 37(3):412-6. PubMed ID: 2351326
[TBL] [Abstract][Full Text] [Related]
14. Methotrexate with citrovorum factor rescue as primary therapy for gestational trophoblastic disease.
Berkowitz RS; Goldstein DP; Bernstein MR
Cancer; 1982 Nov; 50(10):2024-7. PubMed ID: 6290020
[TBL] [Abstract][Full Text] [Related]
15. Methotrexate with citrovorum factor rescue for nonmetastatic gestational trophoblastic neoplasms.
Goldstein DP; Goldstein PR; Bottomley P; Osathanondh R; Marean AR
Obstet Gynecol; 1976 Sep; 48(3):321-3. PubMed ID: 181702
[TBL] [Abstract][Full Text] [Related]
16. Methotrexate with citrovorum factor in low-risk gestational trophoblastic tumor.
Bolis G; Colombo N; Epis A; Mangili G; Vassena L; Vergadoro F; Belloni C
Tumori; 1987 Jun; 73(3):309-13. PubMed ID: 3037744
[TBL] [Abstract][Full Text] [Related]
17. Nonmetastatic gestational trophoblastic disease. Weekly methotrexate compared with 8-day methotrexate-folinic acid.
Gleeson NC; Finan MA; Fiorica JV; Robert WS; Hoffman MS; Wilson J
Eur J Gynaecol Oncol; 1993; 14(6):461-5. PubMed ID: 7514124
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness and toxicity of first-line methotrexate chemotherapy in low-risk postmolar gestational trophoblastic neoplasia: The New England Trophoblastic Disease Center experience.
Maestá I; Nitecki R; Horowitz NS; Goldstein DP; de Freitas Segalla Moreira M; Elias KM; Berkowitz RS
Gynecol Oncol; 2018 Jan; 148(1):161-167. PubMed ID: 29092742
[TBL] [Abstract][Full Text] [Related]
19. Treatment of low-risk metastatic gestational trophoblastic tumors with single-agent chemotherapy.
Roberts JP; Lurain JR
Am J Obstet Gynecol; 1996 Jun; 174(6):1917-23; discussion 1923-4. PubMed ID: 8678159
[TBL] [Abstract][Full Text] [Related]
20. Methotrexate with citrovorum factor rescue: reduced chemotherapy toxicity in the management of gestational trophoblastic neoplasms.
Berkowitz RS; Goldstein DP; Jones MA; Marean AR; Bernstein MR
Cancer; 1980 Feb; 45(3):423-6. PubMed ID: 6243507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]